How can we improve the quality of transplantable lungs?

References

• Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19(12):1199–1204.
   PubMed Web of Science ®Google Scholar
• Orens JB, Boehler A, De Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22(11):1183–1200.
   PubMed Web of Science ®Google Scholar
• Snell GI, Westall GP, Oto T. Donor risk prediction: how ‘extended’ is safe? Curr Opin Organ Transplant. 2013;18(5):507–512.
   PubMed Web of Science ®Google Scholar
• Reyes KG, Mason DP, Thuita L, et al. Guidelines for donor lung selection: time for revision? Ann Thorac Surg. 2010;89(6):1756–1764;discussion 1764–1755.
   Web of Science ®Google Scholar
• Kotloff RM, Blosser S, Fulda GJ, et al. Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43(6):1291–1325.
   PubMed Web of Science ®Google Scholar
• Snell GI, Griffiths A, Levvey BJ, et al. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant. 2008;27(6):662–667.
   PubMed Web of Science ®Google Scholar
• Snell GI, Westall GP. Selection and management of the lung donor. Clin Chest Med. 2011;32(2):223–232.
   PubMed Web of Science ®Google Scholar
• Avlonitis VS, Fisher AJ, Kirby JA, et al. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation. 2003;75(12):1928–1933.
   PubMed Web of Science ®Google Scholar
• Avlonitis VS, Wigfield CH, Kirby JA, et al. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transpl. 2005;5(4 Pt 1):684–693.
   PubMed Web of Science ®Google Scholar
• Bansal R, Esan A, Hess D, et al. Mechanical ventilatory support in potential lung donor patients. Chest. 2014;146(1):220–227.
   PubMed Web of Science ®Google Scholar
• Andreasson AS, Dark JH, Fisher AJ. Ex vivo lung perfusion in clinical lung transplantation–state of the art. Eur J Cardiothorac Surg. 2014;46(5):779–788.
   PubMed Web of Science ®Google Scholar
• Valapour M, Skeans MA, Heubner BM, et al. OPTN/SRTR 2013 annual data report: lung. Am J Transpl. 2015;15(Suppl 2):1–28.
   PubMed Web of Science ®Google Scholar
• Thabut G, Mal H, Cerrina J, et al. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant. 2005;24(9):1347–1353.
   PubMed Web of Science ®Google Scholar
• Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med. 2006;174(6):710–716.
   PubMed Web of Science ®Google Scholar
• Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. Jama. 2010;304(23):2620–2627.
   PubMed Web of Science ®Google Scholar
• Kirschbaum CE, Hudson S. Increasing organ yield through a lung management protocol. Prog Transplant. 2010;20(1):28–32.
   PubMed Web of Science ®Google Scholar
• Noiseux N, Nguyen BK, Marsolais P, et al. Pulmonary recruitment protocol for organ donors: a new strategy to improve the rate of lung utilization. Transplant Proc. 2009;41(8):3284–3289.
   PubMed Web of Science ®Google Scholar
• Riou B, Guesde R, Jacquens Y, et al. Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med. 1994;150(2):558–560.
   PubMed Web of Science ®Google Scholar
• Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 1999;160(1):265–271.
   PubMed Web of Science ®Google Scholar
• Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85(1):278–286;discussion 286.
   PubMed Web of Science ®Google Scholar
• Saxena P, Zimmet AD, Snell G, et al. Procurement of lungs for transplantation following donation after circulatory death: the Alfred technique. J Surg Res. 2014;192(2):642–646.
   PubMed Web of Science ®Google Scholar
• Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation. 1999;67(3):343–348.
   PubMed Web of Science ®Google Scholar
• Smith M. Physiologic changes during brain stem death–lessons for management of the organ donor. J Heart Lung Transplant. 2004;23(9 Suppl):S217–222.
   PubMed Web of Science ®Google Scholar
• Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med. 2004;351(26):2730–2739.
   PubMed Web of Science ®Google Scholar
• Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg. 2001;136(12):1377–1380.
   PubMedGoogle Scholar
• Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75(4):482–487.
   PubMed Web of Science ®Google Scholar
• Rech TH, Moraes RB, Crispim D, et al. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation. 2013;95(7):966–974.
   PubMed Web of Science ®Google Scholar
• Dupuis S, Amiel JA, Desgroseilliers M, et al. Corticosteroids in the management of brain-dead potential organ donors: a systematic review. Br J Anaesth. 2014;113(3):346–359.
   PubMed Web of Science ®Google Scholar
• Shemie SD, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ. 2006;174(6):S13–32.
   PubMed Web of Science ®Google Scholar
• Minambres E, Coll E, Duerto J, et al. Effect of an intensive lung donor-management protocol on lung transplantation outcomes. J Heart Lung Transplant. 2014;33(2):178–184.
   PubMed Web of Science ®Google Scholar
• Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825–829.
   PubMed Web of Science ®Google Scholar
• Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet. 2012;380(9856):1851–1858.
   PubMed Web of Science ®Google Scholar
• Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant. 2012;31(3):274–281.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27(12):1319–1325.
   PubMed Web of Science ®Google Scholar
• Wallinder A, Ricksten SE, Silverborn M, et al. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Eur J Cardiothorac Surg. 2014;45(1):40–44;discussion 44–45.
   PubMed Web of Science ®Google Scholar
• Aigner C, Slama A, Hotzenecker K, et al. Clinical ex vivo lung perfusion–pushing the limits. Am J Transpl. 2012;12(7):1839–1847.
   PubMed Web of Science ®Google Scholar
• Cypel M, Keshavjee S. Extending the donor pool: rehabilitation of poor organs. Thorac Surg Clin. 2015;25(1):27–33.
   PubMed Web of Science ®Google Scholar
• Hidalgo MA, Shah KA, Fuller BJ, et al. Cold ischemia-induced damage to vascular endothelium results in permeability alterations in transplanted lungs. J Thorac Cardiovasc Surg. 1996;112(4):1027–1035.
   PubMed Web of Science ®Google Scholar
• Yeung JC, Cypel M, Machuca TN, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant. 2012;31(10):1120–1126.
   PubMed Web of Science ®Google Scholar
• Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 2001;163(1):259–265.
   PubMed Web of Science ®Google Scholar
• Machuca TN, Mercier O, Collaud S, et al. Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transpl. 2015;15(4):993–1002.
   PubMed Web of Science ®Google Scholar
• Wallinder A, Ricksten SE, Hansson C, et al. Transplantation of initially rejected donor lungs after ex vivo lung perfusion. J Thorac Cardiovasc Surg. 2012;144(5):1222–1228.
   PubMed Web of Science ®Google Scholar
• Valenza F, Citerio G, Palleschi A, et al. Successful transplantation of lungs from an uncontrolled donor after circulatory death preserved in situ by alveolar recruitment maneuvers and assessed by ex vivo lung perfusion. Am J Transpl. 2016;16(4):1312–1318.
   PubMed Web of Science ®Google Scholar
• Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83(6):2191–2194.
   PubMed Web of Science ®Google Scholar
• Ruiz I, Gavalda J, Monforte V, et al. Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transpl. 2006;6(1):178–182.
   PubMed Web of Science ®Google Scholar
• Avlonitis VS, Krause A, Luzzi L, et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg. 2003;24(4):601–607.
   PubMed Web of Science ®Google Scholar
• Nakajima D, Cypel M, Bonato R, et al. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transpl. 2016;16(4):1229–1237.
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg. 2005;129(5):1144–1152.
   PubMed Web of Science ®Google Scholar
• Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant. 2008;27(11):1229–1236.
   PubMed Web of Science ®Google Scholar
• Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant. 2007;26(10):1054–1060.
   PubMed Web of Science ®Google Scholar
• Machuca TN, Hsin MK, Ott HC, et al. Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med. 2013;188(7):878–880.
   PubMed Web of Science ®Google Scholar
• Fischer S, Liu M, MacLean AA, et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Human Gene Therapy. 2001;12(12):1513–1526.
   PubMed Web of Science ®Google Scholar
• Martins S, De Perrot M, Imai Y, et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 2004;11(24):1786–1796.
   PubMed Web of Science ®Google Scholar
• Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009;106(38):16357–16362.
   PubMed Web of Science ®Google Scholar
• Inci I, Arni S, Acevedo C, et al. Surfactant alterations following donation after cardiac death donor lungs. Transpl Int Off J Eur Soc Transpl. 2011;24(1):78–84.
   PubMed Web of Science ®Google Scholar
• Ohsumi A, Chen F, Sakamoto J, et al. Protective effect of pre-recovery surfactant inhalation on lungs donated after cardiac death in a canine lung transplantation model. J Heart Lung Transplant. 2012;31(10):1136–1142.
   PubMed Web of Science ®Google Scholar
• Ohsumi A, Chen F, Nakajima D, et al. Therapeutic effect of surfactant inhalation during warm ischemia in an isolated rat lung perfusion model. Transpl Int Off J Eur Soc Transpl. 2012;25(10):1096–1105.
   PubMed Web of Science ®Google Scholar
• Heusch G, Botker HE, Przyklenk K, et al. Remote ischemic conditioning. J Am Coll Cardiol. 2015;65(2):177–195.
   PubMed Web of Science ®Google Scholar
• Meng C, Ma L, Niu L, et al. Protection of donor lung inflation in the setting of cold ischemia against ischemia-reperfusion injury with carbon monoxide, hydrogen, or both in rats. Life Sci. 2016;151:199–206.
   PubMed Web of Science ®Google Scholar
• Kohmoto J, Nakao A, Stolz DB, et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transpl. 2007;7(10):2279–2290.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Tang X, Janocha A, et al. Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2013;145(4):1108–1116.
   PubMed Web of Science ®Google Scholar
• Sugimoto R, Okamoto T, Nakao A, et al. Nitrite reduces acute lung injury and improves survival in a rat lung transplantation model. Am J Transpl. 2012;12(11):2938–2948.
   PubMed Web of Science ®Google Scholar
• Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16(8):927–933.
   PubMed Web of Science ®Google Scholar
• Gilpin SE, Ott HC. Using nature’s platform to engineer bio-artificial lungs. Ann Am Thorac Soc. 2015;12(Suppl 1):S45–49.
   PubMedGoogle Scholar